Masahiko Ando

Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer

Tomoki Ebata, Satoshi Hirano, Masaru Konishi et al. · British journal of surgery · 2018 · 395 citations

Medicine, Oncology, Cancer Control +12

Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904)

Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa et al. · Journal of Clinical Oncology · 2006 · 366 citations · Full text

Medicine, Oncology, Pharmacology +10

Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Masahiko Ando, Isamu Okamoto, Nobuyuki Yamamoto et al. · Journal of Clinical Oncology · 2006 · 361 citations

Medicine, Oncology, Pharmacology +13

Risk Factors for Drug-Resistant Pathogens in Community-acquired and Healthcare-associated Pneumonia

Yuichiro Shindo, Ryota Ito, Daisuke Kobayashi et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 292 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +16

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

K. Yamazaki, Michitaka Nagase, H Tamagawa et al. · Annals of Oncology · 2016 · 282 citations · Full text

Medicine, Oncology, Pharmacotherapy +8